294 related articles for article (PubMed ID: 26115203)
1. Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin.
Freeman R; Wallace MS; Sweeney M; Backonja MM
Pain Med; 2015 Oct; 16(10):2000-11. PubMed ID: 26115203
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin: Interaction of Patient Demographics, Disease Characteristics, and Efficacy Outcomes.
Kantor D; Panchal S; Patel V; Bucior I; Rauck R
J Pain; 2015 Dec; 16(12):1300-1311. PubMed ID: 26409117
[TBL] [Abstract][Full Text] [Related]
3. Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin.
Mehta N; Bucior I; Bujanover S; Shah R; Gulati A
Health Qual Life Outcomes; 2016 Apr; 14():54. PubMed ID: 27037091
[TBL] [Abstract][Full Text] [Related]
4. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M
J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085
[TBL] [Abstract][Full Text] [Related]
5. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
Sang CN; Sathyanarayana R; Sweeney M;
Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
[TBL] [Abstract][Full Text] [Related]
6. Early pain reduction can predict treatment response: results of integrated efficacy analyses of a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgia.
Jensen MP; Hsu PH; Vanhove GF
Pain Med; 2012 Aug; 13(8):1059-66. PubMed ID: 22757655
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.
Jensen MP; Irving G; Rauck R; Wallace M; Sweeney M; Vanhove GF
Clin J Pain; 2013 Sep; 29(9):770-4. PubMed ID: 23370075
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.
Gupta A; Li S
Drugs Aging; 2013 Dec; 30(12):999-1008. PubMed ID: 24163280
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.
Wallace MS; Irving G; Cowles VE
Clin Drug Investig; 2010; 30(11):765-76. PubMed ID: 20818838
[TBL] [Abstract][Full Text] [Related]
10. Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia.
Jensen MP; Chiang YK; Wu J
Clin J Pain; 2009 May; 25(4):286-92. PubMed ID: 19590476
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.
Irving G; Jensen M; Cramer M; Wu J; Chiang YK; Tark M; Wallace M
Clin J Pain; 2009; 25(3):185-92. PubMed ID: 19333167
[TBL] [Abstract][Full Text] [Related]
12. Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials.
Wang J; Zhu Y
J Dermatolog Treat; 2017 Feb; 28(1):65-77. PubMed ID: 27798973
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin for chronic neuropathic pain in adults.
Wiffen PJ; Derry S; Bell RF; Rice AS; Tölle TR; Phillips T; Moore RA
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007938. PubMed ID: 28597471
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
Backonja MM; Canafax DM; Cundy KC
Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial.
Chandra K; Shafiq N; Pandhi P; Gupta S; Malhotra S
Int J Clin Pharmacol Ther; 2006 Aug; 44(8):358-63. PubMed ID: 16961166
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study.
Lee EG; Lee HJ; Hyun DJ; Min K; Kim DH; Yoon MS
Dermatol Ther; 2016 May; 29(3):184-90. PubMed ID: 26799145
[TBL] [Abstract][Full Text] [Related]
18. Clinical development of a once-daily gastroretentive formulation of gabapentin for treatment of postherpetic neuralgia: an overview.
Argoff CE; Chen C; Cowles VE
Expert Opin Drug Deliv; 2012 Sep; 9(9):1147-60. PubMed ID: 22809245
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.
Rowbotham M; Harden N; Stacey B; Bernstein P; Magnus-Miller L
JAMA; 1998 Dec; 280(21):1837-42. PubMed ID: 9846778
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
